The Preventive and Therapeutic Vaccine Market Increasing government funding for vaccine development, rising R&D investments, the introduction of faster vaccine development technologies, and improvements in vaccine design are some of the factors, which will fuel market growth over the coming years. However, the high cost of vaccine storage and transportation and stringent regulations for the approval of vaccines will hamper the market expansion.

1. © 2016 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com
Fuel Cell Market size worth $25.5bn by 2024
Low Power Wide Area Network
Preventive and Therapeutic Vaccine Market Size, Industry
Analysis Report, Regional Outlook- 2017-2024.: Global
Market Insights Inc.

2. © 2016 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com
 Increasing government funding for vaccine development, rising R&D investments,
the introduction of faster vaccine development technologies, and improvements in
vaccine design are some of the factors, which will fuel market growth over the
coming years. However, the high cost of vaccine storage and transportation and
stringent regulations for the approval of vaccines will hamper the market expansion.

 Global preventive and therapeutic vaccine market is broadly classified into
preventive vaccine market and therapeutic vaccine market. Based on the product
type, preventive vaccine market is segmented into pediatric and adult vaccines and
therapeutic vaccine is segmented into neurological disease vaccines, autoimmune
disease vaccines, infectious disease vaccines, and cancer vaccines.
Application of Chemical Anal Preventive and Therapeutic
Vaccine yzers Market :

3. © 2016 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com
 Some of the major players in the global preventive and therapeutic vaccine
market are Sanofi Pasteur, Merck & Co., Pfizer, and GlaxoSmithKline.
 The largest players account for approximately 80% of the global revenue.
AstraZeneca, Johnson & Johnson, CSL, and Emergent Biosolutions are the
other notable industry players.
Key Vendors of Preventive and Therapeutic Vaccine Market :

4. © 2016 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com
 Latin America therapeutic vaccines targeting cancers and allergies offer vast
opportunities for fresh players entering this regional market. First FDA-
approved therapeutic vaccine, Provenge by Dendreon, treating prostate cancer
acknowledged the potential of vaccines in therapeutics.
 Saudi Arabia and South Africa dominates the Middle East & Africa preventive
and therapeutic vaccine market. R&D funding for diseases, such as HIV and
cancer, by the government offers a novel opportunity for the vaccine market.
Wide usage of vaccines includes, inactivated, live attenuated, toxoid, subunit,
conjugate, dendritic cell, and synthetic. Preventive vaccine is the leading type
due to high awareness among people.
Regional Analysis of Preventive and Therapeutic Vaccine
Market

5. © 2016 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com
Browse Full Market Research Report On Preventive and
Therapeutic Vaccine Market @ http://bit.ly/2sgImzd
Request for an in-depth table of contents for this report @
http://bit.ly/2r8XHR7

6. © 2016 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com
Stay In Touch
Website: www.gminsights.com
Social Media: